Cite
HARVARD Citation
Mohammadi, M. et al. (2023). A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity. Journal of immunotherapy. 46 (4), pp. 121-131. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mohammadi, M. et al. (2023). A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity. Journal of immunotherapy. 46 (4), pp. 121-131. [Online].